Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure.
about
Impact of inflammation on the osteoblast in rheumatic diseasesCD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritisAutomated three-dimensional registration of high-resolution peripheral quantitative computed tomography data to quantify size and shape changes of arthritic bone erosions.A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab.Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.Validity of a computer-assisted manual segmentation software to quantify wrist erosion volume using computed tomography scans in rheumatoid arthritis.A customized protocol to assess bone quality in the metacarpal head, metacarpal shaft and distal radius: a high resolution peripheral quantitative computed tomography precision studyOsteoimmunology and osteoporosis.Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modificationProtective effects of tumor necrosis factor-α blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritisEfficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.Focal bone involvement in inflammatory arthritis: the role of IL17.Imaging in rheumatoid arthritis: options, uses and optimization.Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage.Assessment of 3-month changes in bone microstructure under anti-TNFα therapy in patients with rheumatoid arthritis using high-resolution peripheral quantitative computed tomography (HR-pQCT).Quantification of bone changes in a collagen-induced arthritis mouse model by reconstructed three dimensional micro-CT.Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis.Skeletal complications of rheumatoid arthritis.Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?Volume measurement of bone erosions in magnetic resonance images of patients with rheumatoid arthritis.Measuring bone erosion and edema in rheumatoid arthritis: a comparison of manual segmentation and RAMRIS methods.A comparative analysis of magnetic resonance imaging and high-resolution peripheral quantitative computed tomography of the hand for the detection of erosion repair in rheumatoid arthritis.Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.Bone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications
P2860
Q26829246-530D1112-7F26-489F-90A9-5DACCA3F425CQ28728734-BAC6A48A-1292-4704-9EE9-6313F18093B0Q30980452-DC509F46-65A5-4E49-9523-C78215287636Q33731695-D0253244-0316-4611-9CF7-767BC0B4B8D6Q33896725-E0CCC33D-76A8-4062-B39F-D16ACDE0A28DQ34545263-0E6DA5B7-28C1-44A8-9BEF-7E14071AB2F9Q34985756-A927912E-06C1-4E1C-90B0-4F129FC76372Q35074535-3ED87049-1B74-4981-BD53-18B36E17D4E4Q35840701-6F3847E3-C528-476C-824C-F048324F075FQ36020188-4F67B5EC-49A7-4104-908D-33C3CE8C2D61Q36196730-BD74EB2F-874B-4256-8D58-97260353B0DDQ37873493-202C07EF-D989-47DB-9A56-287040B2CFC7Q37882064-E08CA30E-BC3B-47A1-A0B0-63F6C64AB93AQ38295616-06D8427F-AF06-49C9-A103-C293ECB2EC52Q38590254-63E87C50-3D20-48F3-917F-52057BFEA103Q38593977-0E30CEF3-4C4F-4689-A12B-E80B9F8DF470Q39341743-9D3FAFAF-A50F-4839-A903-6179D6A4E21DQ42161702-D8409864-DB26-4A02-BB84-B645296B062EQ43073717-D58E3962-5747-4F7A-AE5D-2477CBAD929CQ47749650-2F5815C1-7A89-4CB4-9576-642F0A68CB78Q47805955-E7AB3E6F-5B64-497D-8D7F-74EB3B8FBF5DQ51530420-A4B73654-FDA4-4304-980B-9EBC69284D39Q51556218-921AE273-B994-4BBE-87F4-49673DF5A45BQ51608924-F0EF9AD1-EF3D-4D0A-B090-C38EEE31DB83Q53017856-5489A5AB-C0B8-4152-A4F9-6BB2C0630C17Q53085402-A1365B45-2AF7-4BEB-8CA5-3D00ED988F8DQ58774487-56235B93-D921-4E1B-A11B-C642CC641FFE
P2860
Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Erosive progression is minimal ...... s the primary outcome measure.
@en
Erosive progression is minimal ...... s the primary outcome measure.
@nl
type
label
Erosive progression is minimal ...... s the primary outcome measure.
@en
Erosive progression is minimal ...... s the primary outcome measure.
@nl
prefLabel
Erosive progression is minimal ...... s the primary outcome measure.
@en
Erosive progression is minimal ...... s the primary outcome measure.
@nl
P2093
P356
P1476
Erosive progression is minimal ...... as the primary outcome measure
@en
P2093
L S Knudsen
M Hasselquist
M S Hansen
M Østergaard
O R Madsen
U Møller Døhn
P304
P356
10.1136/ARD.2008.097048
P407
P577
2008-11-19T00:00:00Z